Commercialization of COVID-19 Vaccines, Treatments, and Tests: Implications for Access and Coverage
-
By Reports on Health Insurance and Health Care Costs from the Kaiser Family Foundation in access to care, affordability, Coronavirus (COVID-19), health costs, Kaiser Family Foundation, Medicaid, Medicare, Private Insurance, Uninsured, Vaccines
-
October 18, 2022
With the depletion of the federal-purchased supply of COVID-19 vaccines, treatments and tests following the end of the public health emergency, this resource provides an overview of the implications of these changes for access to people covered by Medicare, Medicaid and private insurance, as well as those who are uninsured.
Read the full post on Reports on Health Insurance and Health Care Costs from the Kaiser Family Foundation
Reports on Health Insurance and Health Care Costs from the Kaiser Family Foundation
